The British Medical Journal, the leading peer-reviewed medical journal of the British Medical Association, recently published an article stating that the evidence supporting the approval of transgender treatments for children is minimal.
The journal’s editor-in-chief, Kamran Abbasi, argues in the article that the evidence to support certain pharmacological and surgical treatments for children with gender dysphoria is limited and that it is difficult to point with certainty to a way forward.
In fact, the Tavistock clinic, the only gender clinic for children in England, was closed a few months ago by the National Health Service (NHS) after an independent investigation into the center revealed that doctors were pushing children to change sex after conducting superficial examinations, often without considering the implications related to their mental health.
NHS England has also banned the administration of puberty blockers for minors outside of rigorous clinical trials and plans to restrict other sex-change treatments, citing that there is currently “scant and inconclusive evidence to support such clinical decision-making.”